Asia-Pacific Prazosin Market Growth, Size, Share, Industry Report and Forecast 2020-2026
Asia-Pacific prazosin market is estimated to decline during the forecast period. However, some factors are positively influencing market growth to some extent. According to the European Society of Cardiology (ESC) in 2018, a report presented by a team of scientists suggested that one in five young adults in India has high blood pressure, which equals to nearly 80 million adults. The major risk factors for high blood pressure in the region include smoking, tobacco chewing, diabetes mellitus, and high cholesterol. Further, prazosin finds application in the treatment of various other conditions such as BPH, congestive heart failure, pheochromocytoma (adrenal gland tumor), sleep problems associated with PTSD; an anxiety disorder in people who experience or witness a traumatic, life-threatening event. However, due to the availability of alternatives the market for prazosin is projected to decline in the region.
To Request a Sample of our Report on Asia-Pacific Prazosin Market: https://www.omrglobal.com/request-sample/asia-pacific-prazosin-market
Asia-Pacific
prazosin market is segmented on the basis of application. Based on the
application, the market is segmented into cardiovascular disease, neurological
syndromes, prostate disorders, and kidney disorders. The CVD segment accounted
for a significant share in the Asia-Pacific prazosin market. CVDs claim to take
more lives each year than all forms of cancer and chronic lower respiratory
diseases altogether. Thus, Prazosin is one of the treatments used for CVD
mainly high BP and strokes. For instance, Minipress is specified for the
treatment of hypertension, to control BP. Lowering blood pressure decreases the
risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial
infarction.
A full
Report of Asia-Pacific Prazosin Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-prazosin-market
·
Cardiovascular
Disease(CVD)
·
Neurological
Syndromes
·
Prostate
Disorders
·
Kidney
Disorders
Regional
Analysis
·
China
·
India
·
Japan
Rest of
Asia-Pacific
Company
Profiles
·
Ajinomoto
Co., Inc.
·
Johnlee
Pharmaceuticals Pvt. Ltd.
·
Merck
KGaA
·
Pfizer
Inc.
·
R&D
Systems Inc.
·
Renata
Ltd.
·
Mylan
N.V.
·
Standard
Chem and Pharmaceuticals Co. Ltd.
·
Sun
Pharmaceuticals Industries Ltd.
·
Teva
Pharmaceuticals Industries Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-prazosin-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment